PI3K/mTOR inhibitors were found to be amongst the top ranked drugs, and thus suggested as treatment for patients with early EEC, and for the non-obese group in particular (Supplementary Table S5). The gene discussed is PIK3CA; the disease is exstrophy-epispadias complex.